Cadila Health
BSE: 532321
|
NSE: CADILAHC
Cadila Health
(CIN: L24230GJ1995PLC025878)
operates in the Pharmaceuticals industry and has been listed in the stock market since 27 Apr 2000.
It currents trades on NSE with symbol CADILAHC and on BSE with scrip code 532321.
The registered office of the company is Zydus Corporate Park, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Sarkhej - Gandhinagar Highway, Nr. Vaishnodevi Circle, Ahmedabad, Gujarat - 382481.
The management team of Cadila Health is led by Pankaj R. Patel who is the Non-Executive - Non Independent Director-Chairperson related to Promoter. Other members of the management team consist of Sharvil P. Patel (Designation:Executive Director-MD), Ganesh N. Nayak (Designation:Executive Director), Mukesh M. Patel (Designation:Non-Executive - Non Independent Director), Apurva S. Diwanji (Designation:Non-Executive - Independent Director), Bhadresh K. Shah (Designation:Non-Executive - Independent Director), Akhil Monappa (Designation:Non-Executive - Independent Director), Upasana Konidela (Designation:Non-Executive - Independent Director), Shelina Parikh (Designation:Non-Executive - Independent Director), Nitin D Parekh (Designation:Chief Financial Officer), Dhaval N. Soni (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Cadila Health is as below -
The registered office of the company is Zydus Corporate Park, Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Sarkhej - Gandhinagar Highway, Nr. Vaishnodevi Circle, Ahmedabad, Gujarat - 382481.
The management team of Cadila Health is led by Pankaj R. Patel who is the Non-Executive - Non Independent Director-Chairperson related to Promoter. Other members of the management team consist of Sharvil P. Patel (Designation:Executive Director-MD), Ganesh N. Nayak (Designation:Executive Director), Mukesh M. Patel (Designation:Non-Executive - Non Independent Director), Apurva S. Diwanji (Designation:Non-Executive - Independent Director), Bhadresh K. Shah (Designation:Non-Executive - Independent Director), Akhil Monappa (Designation:Non-Executive - Independent Director), Upasana Konidela (Designation:Non-Executive - Independent Director), Shelina Parikh (Designation:Non-Executive - Independent Director), Nitin D Parekh (Designation:Chief Financial Officer), Dhaval N. Soni (Designation:Company Secretary & Compliance Officer), .
The price and other financial information of Cadila Health is as below -
Volume: 30,035.00
M. Cap: 1,04,503.93
P/E: 20.40
Prev. Close: 1,036.20
Day
52 Wk
Volume: 11,64,629.00
M. Cap: 1,04,584.43
P/E: 20.40
Prev. Close: 1,036.45
Day
52 Wk
Stock Price Chart
F&O Data
Shareholding Pattern
| Category | No. of shares | Percent(%) |
|---|---|---|
| Promoters | 75,46,25,314 | 75.00 |
| Pledge | 0 | 0.00 |
| Foreign Institutions | 6,98,85,360 | 6.94 |
| Financial Institutions | 11,23,92,336 | 11.17 |
| NBFC and Mutual Funds | 4,90,65,382 | 4.88 |
| Others | 6,93,30,980 | 6.89 |
| Total | 1,05,52,99,372 | 104.88 |
NSE Trade Data
| VWAP | - |
| Face Value | - |
| Traded Volume (shares) | - |
| Traded Value (lacs) | - |
| Free Float Market Cap (Crs) | - |
| 52 week high | - |
| 52 week low | - |
| Lower Price Band | - |
| Upper Price Band | - |
Security-wise Delivery Position
| Quantity Traded | - |
| Deliverable Quantity (gross across client level) | - |
| % of Deliverable Quantity to Traded Quantity | - |
Value at Risk (VaR in %)
| Security VaR | - |
| Index VaR | - |
| VAR Margin | - |
| Extreme Loss Rate | - |
| Adhoc Margin | - |
| Applicable Margin Rate | - |
Financial Data
Consolidated
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 23,241.50 | 19,547.40 | 17,237.40 |
| Operating Profit | 7,108.40 | 5,677.20 | 3,437.70 |
| Other Income | 269.50 | 310.60 | 186.60 |
| Interest | 165.90 | 81.20 | 129.90 |
| Depreciation | 915.80 | 764.10 | 722.70 |
| Profit Before Tax | 6,026.70 | 4,831.90 | 2,585.10 |
| Tax | 1,411.90 | 977.50 | 587.80 |
| Profit After Tax | 4,614.80 | 3,854.40 | 1,997.30 |
| Share Capital | 100.60 | 100.60 | 101.20 |
| Reserves | 23,852.50 | 19,728.90 | 17,414.60 |
| Net Worth | 23,953.10 | 19,829.50 | 17,515.80 |
| Loans | 4,470.20 | 2,172.10 | 1,522.10 |
| Gross Block | 21,699.80 | 19,919.80 | 18,343.80 |
| Investments | 6,407.80 | 1,220.50 | 1,546.60 |
| Cash | 2,956.80 | 1,105.10 | 573.10 |
| Debtors | 4,024.70 | 5,220.20 | 4,416.80 |
| Net Working Capital | 8,595.20 | 8,261.40 | 6,942.20 |
| Operating Profit Margin (%) | 30.58 | 29.04 | 19.94 |
| Net Profit Margin (%) | 19.86 | 19.72 | 11.59 |
| EPS | 44.99 | 38.36 | 19.37 |
| Dividend (%) | 1,100.00 | 300.00 | 600.00 |
| Dividend Payout | 301.90 | 620.80 | 266.50 |
Standalone
| Figures in crore | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Sales | 15,116.30 | 10,818.70 | 8,731.60 |
| Operating Profit | 8,432.50 | 5,134.90 | 2,799.00 |
| Other Income | 696.20 | 1,084.80 | 548.40 |
| Interest | 463.90 | 390.70 | 278.20 |
| Depreciation | 523.90 | 504.40 | 488.60 |
| Profit Before Tax | 7,444.70 | 4,239.80 | 2,032.20 |
| Tax | 1,669.80 | 798.30 | 503.00 |
| Profit After Tax | 5,774.90 | 3,441.50 | 1,529.20 |
| Share Capital | 100.60 | 100.60 | 101.20 |
| Reserves | 21,089.50 | 15,615.90 | 13,538.20 |
| Net Worth | 21,190.10 | 15,716.50 | 13,639.40 |
| Loans | 8,607.80 | 6,388.00 | 4,991.50 |
| Gross Block | 8,899.60 | 8,677.40 | 7,999.80 |
| Investments | 11,491.50 | 7,283.00 | 4,879.30 |
| Cash | 144.10 | 414.40 | 248.10 |
| Debtors | 8,161.80 | 4,740.10 | 3,505.30 |
| Net Working Capital | 12,915.80 | 9,818.20 | 8,828.20 |
| Operating Profit Margin (%) | 55.78 | 47.46 | 32.06 |
| Net Profit Margin (%) | 38.20 | 31.81 | 17.51 |
| Earning Per Share (Rs) | 57.40 | 34.21 | 15.11 |
| Dividend (%) | 1,100.00 | 300.00 | 600.00 |
| Dividend Payout | 301.90 | 607.30 | 253.00 |
| Bonus History | Date | Ratio |
|---|---|
| 05 Apr 2010 | issue issue 1:2 |
Financial Data Graph
The peers of Cadila Health are SUNPHARMA, DRREDDY and AUROPHARMA. You can get more detailed information on those company by clicking on the respective names.
* The above data is collected from public sources and we do not guarantee the accuracy of the same.*
Popular Comments
No comment posted for this article.